甘精胰岛素联合瑞格列奈治疗2型糖尿病的临床疗效观察

Observation on the Clinical Curative Effect of Insulin Glargine Combined With Repaglinide in the Treatment of Type 2 Diabetes

目的探讨甘精胰岛素联合瑞格列奈治疗2型糖尿病临床疗效。方法选取2016年4月—2017年4月到我院进行治疗的2型糖尿病患者100例,将100例患者随机分为两组,对照组患者使用常规胰岛素对患者进行皮下注射,实验组患者使用甘精胰岛素,记录两组患者的治疗有效率。结果实验组对患者治疗有效率为94.00%,对照组患者治疗有效率为78.00%,数据对比差异具有统计学意义(P<0.05)。结论临床对2型糖尿病的治疗,可以使用甘精胰岛素联合瑞格列奈的方法进行治疗,治疗效果更有效。

Objective To investigate the effect of insulin glargine combined with repaglinide in the treatment of type 2 diabetes mellitus. Methods 100 patients were selected from April 2016 to April 2017 in our hospital for the treatment of type 2 diabetes, 100 patients were randomly divided into two groups, the control group was treated with routine insulin subcutaneous injection for patients, patients in the experimental group was treated with insulin glargine treatment, efficiency in two groups of patients was recorded. Results The effective rate of the experimental group was 94%, while the effective rate of the control group was 78%. There was significant difference between the two groups （P 〈 0.05）. Conclusion The clinical treatment of type 2 diabetes, can use insulin glargine combined with repaglinide for treatment, the treatment 1s more effective.